Toxicity and quality of life after adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): an open-label, multicentre, randomised, phase 3 trial
de Boer, Stephanie M, Dr, Powell, Melanie E, MD, Mileshkin, Linda, MD, Katsaros, Dionyssios, Prof, Bessette, Paul, Prof, Haie-Meder, Christine, MD, Ottevanger, Petronella B, MD, Ledermann, Jonathan A, Prof, Khaw, Pearly, MD, Colombo, Alessandro, MD, Fyles, Anthony, Prof, Baron, Marie-Helene, MD, Kitchener, Henry C, Prof, Nijman, Hans W, Prof, Kruitwagen, Roy F, Prof, Nout, Remi A, MD, Verhoeven-Adema, Karen W, PhD, Smit, Vincent T, Prof, Putter, Hein, Prof, Creutzberg, Carien L, Prof
Published in The lancet oncology (01.08.2016)
Published in The lancet oncology (01.08.2016)
Get full text
Journal Article